Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 8, 2001

View Archived Issues

Pharmacia Spins Off Metabolic Disease Business Into Biovitrum

Ionix Secures #8M In First Round For Ion Channel Work

OSI Acquiring Discovery Arm From British Biotech For $12.4M

Genfit Concludes Two More Deals With Pharma Companies

Compugen, Novartis Collaborate To Accelerate Target Identification

Tibotec-Virco Consolidates Operations In Belgium, U.S.

CellFactors Plans Funding After Getting Bone-Related U.S. Patent

Ichor Changes Name, Continues Focus On Retroviral Diseases

Other News To Note

Pharmexa Plans Spin-Off For Additional Vaccine Applications

Pharming Contemplates Avenues Available To Continue Business

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...